Oral submucous fibrosis: its pathogenesis and management. Br Dent J 1986 Jun;160(12):429-434.
Oral submucous fibrosis: review on etiology and pathogenesis. Oral Oncol 2006 Jul;42(6):561-568.
Characterisation and quantification of mucosal vasculature in oral submucous fibrosis. Indian J Dent Res 2005 Jul-Sep;16(3):83-91.
Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis. Oral Oncol 2010 Jul;46(7):553-558.
Early stage oral submucous fibrosis is characterized by increased vascularity as opposed to advanced stages. J Clin Diagn Res 2017 May;11(5):ZC92-ZC96.
Morphometric analysis of the mucosal vasculature in oral submucous fibrosis and its comparison with oral squamous cell carcinoma. J Oral Sci 2014 Jun;56(2):173-178.
Concomitant examination of inflammation and angiogenesis in the pathogenesis of primary moderate pterygium in a well-designed case-control study. Pak J Biol Sci 2013 Oct;16(19):1046-1050.
Use of a fibrin-based system for enhancing angiogenesis and modulating inflammation in the treatment of hyperglycemic wounds. Biomaterials 2014 Feb;35(6):2001-2010.
Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. Br J Cancer 2014 Jan;110(2):469-478.
The role of vascular endothelial growth factor in inflammatory processes. Postepy Hig Med Dosw (Online) 2014 Jan;68:57-65.
Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 2005 Feb;4(1):3-8.
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut 2014 Dec;63(12):1960-1971.
Cellular and molecular mechanisms in liver fibrogenesis. Arch Biochem Biophys 2014 Apr;548:20-37.
Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin Liver Dis 2010 Aug;30(3):258-270.
Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases. World J Gastroenterol 2010 Jan;16(3):281-288.
Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology 2012 Feb;55(2):622-633.
Angiogenesis in chronic liver disease and its complications. Liver Int 2011 Feb;31(2):146-162.
Angiogenesis: a phenomenon which aggravates chronic liver disease progression. Hepatol Int 2013 Mar;7(1):4-12.
Differential roles of angiogenesis in the induction of fibrogenesis and the resolution of fibrosis in liver. Biol Pharm Bull 2015 Jul;38(7):980-985.
Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum 2007 Dec;56(12):4203-4215.
Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 2003 Nov;121(5):1005-1012.
Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol 2012 Dec;296:139-185.
Matrix stiffening in the formation of blood vessels. Adv Regen Biol 2014 Oct;1(1):25247.
Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats. Respir Res 2013 May;14(1):56.
Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway. Exp Biol Med (Maywood) 2017 May;242(9):974-985.